by Simantini Singh Deo

15 minutes

Top 20 Pharmaceutical Companies In India

A data-backed guide to India's top 20 pharma companies — revenue, focus areas, exports, and how to pick the right manufacturing partner.

Top 20 Pharmaceutical Companies In India

India is often called the "Pharmacy of the World," and for good reason. The country supplies a huge share of the generic medicines used across the globe, and it is also one of the biggest producers of vaccines and active pharmaceutical ingredients, the raw chemical components that go into a finished drug. Behind this reputation is a group of large, well-established Indian pharmaceutical companies that manufacture everything from everyday tablets to complex biosimilars.

India's pharma sector backs up its "Pharmacy of the World" reputation with real scale. The domestic market was valued at roughly ₹4,97,000 crore (~US$57.6 billion) in 2025 and is projected to grow to ₹6,89,000 crore (~US$79.7 billion) by 2031, according to IBEF, citing Mordor Intelligence data. On the export side, India shipped drugs and pharmaceuticals worth ₹2,59,658 crore (~US$30.4 billion) in FY25 — up from ₹2,43,119 crore (~US$27.8 billion) in FY24 — with drug formulations and biologicals alone accounting for about 75% of that figure. India is also the third-largest global producer of active pharmaceutical ingredients, holding an 8% share of the worldwide API industry.

Below is a simple, easy-to-follow list of 20 major pharmaceutical companies in India. Some are giants with global operations, while others are strong regional or specialty players. The order is not a strict ranking, since companies differ in size depending on whether you look at revenue, market value, or export strength, but all twenty are genuine, well-known names in the Indian pharma industry.



No.

Company

HQ / Founded

Countries served

Core focus

FY25 revenue (disclosed)

1

Sun Pharma

Mumbai, 1983

100+

Specialty, generics, dermatology, oncology

~₹52,570 cr (US$6.2 bn)

2

Dr. Reddy's

Hyderabad, 1984

66–76

Generics, APIs, biosimilars, innovative medicines

~₹32,550 cr

3

Cipla

Mumbai, 1935

74–80

Respiratory, HIV/AIDS, chronic care

~₹27,548 cr

4

Divi's Laboratories

Hyderabad (est. 1990)

100+

APIs, custom synthesis, CRAMS

~₹10,029 cr

5

Aurobindo Pharma

Hyderabad, 1986

150+

Generics, APIs, biosimilars

~₹32,514 cr

6

Zydus Lifesciences

Ahmedabad, 1952

55+

Biosimilars, vaccines, complex generics

~₹24,494 cr

7

Lupin

Mumbai, 1968

100+

Respiratory, cardiovascular, diabetes

~₹24,751 cr

8

Mankind Pharma

New Delhi, 1991

India-focused

Consumer healthcare + prescription brands

~₹13,546 cr

9

Torrent Pharmaceuticals

Ahmedabad, early 1970s

Brazil, Germany, US + India

Cardiovascular, CNS

~₹12,248 cr

10

Biocon

Bangalore, 1978

120+

Biosimilars, biologics

~₹16,476 cr

11

Alkem Laboratories

Mumbai, 1973

Domestic-led + US

Anti-infectives, acute therapies

~₹13,890 cr

12

Glenmark Pharmaceuticals

Mumbai (inc. 1977)

80+

Dermatology, respiratory, novel molecules

~₹15,955 cr

13

Ipca Laboratories

Mumbai

100+

Anti-malarials, pain management

~₹9,357 cr

14

Intas Pharmaceuticals

Ahmedabad

85+

Biosimilars, oncology, CNS

Unspecified (private)

15

Emcure Pharmaceuticals

Pune, 1981

70+

Gynecology, HIV, vaccines

~₹8,449 cr

16

Wockhardt

Mumbai

Biopharmaceuticals, antibiotics, hospitals

Not disclosed here

17

Natco Pharma

Hyderabad, 1981

40+

Oncology generics

~₹4,784 cr

18

Ajanta Pharma

Mumbai, 1973

33+

Ophthalmology, cardiology, Africa-focused

~₹4,973 cr

19

Laurus Labs

Hyderabad

Antiretroviral APIs, CDMO

~₹6,722 cr

20

Piramal Pharma

Mumbai (listed entity, 2020)

100+

CDMO, critical care, consumer health

Crossed US$1 bn

Figures are the most recent publicly disclosed revenue as of FY25 filings; where a company is privately held or the figure wasn't confirmable from public disclosures, it's marked "unspecified" rather than estimated. Country-count ranges reflect variation across different official company sources.

Mind map organizing the major market leaders from the top 20 pharmaceutical companies in india.

1) Sun Pharmaceutical Industries

Sun Pharma, founded in 1983 and headquartered in Mumbai, is widely regarded as India's largest pharmaceutical company by revenue and market value. It started small and grew, partly through major acquisitions, into a business with operations in over a hundred countries. Sun Pharma is especially strong in specialty areas like dermatology, oncology, and cardiology, alongside a large generics business, and it also owns a significant stake in Taro Pharmaceuticals, which helped it expand deeper into the US market.


2) Dr. Reddy's Laboratories

Dr. Reddy's Laboratories was founded in 1984 by Dr. Kallam Anji Reddy in Hyderabad, and it went public just two years later. The company built its early reputation on generic medicines and active pharmaceutical ingredients, and it later became one of the first Indian pharma companies to seriously invest in research and development. Today it has a broad global footprint, including a strong US presence, and it has been steadily expanding into biosimilars, close copies of complex biologic drugs.


3) Cipla

Cipla is one of the oldest and most respected names in Indian pharmaceuticals, founded in 1935 by Dr. Khwaja Abdul Hamied in Mumbai. It became internationally famous in the early 2000s for making affordable HIV/AIDS medicines available to patients in developing countries. Cipla has a particularly strong respiratory and inhalation portfolio, including asthma and COPD treatments, and maintains a significant presence across India, Africa, and the United States.


4) Divi's Laboratories

Divi's Laboratories, headquartered in Hyderabad, works differently from most companies on this list because it focuses heavily on active pharmaceutical ingredients and custom manufacturing for global pharma companies, rather than selling its own branded medicines. This model is sometimes called CRAMS, short for Contract Research and Manufacturing Services. Its reputation for reliability and scale has made it one of the most valuable pharma companies in India by market value, despite not being a household consumer name.


5) Aurobindo Pharma

Aurobindo Pharma, based in Hyderabad, has grown into one of India's largest exporters of generic medicines, with products reaching more than 150 countries through a large network of formulation and API manufacturing units. It has secured approvals from major regulators such as the US FDA and the UK's MHRA, and it covers a wide range of therapy areas, including antibiotics, antiretrovirals, and cardiovascular drugs. It also runs AuroZymes, a division supplying biocatalysts to pharmaceutical and chemical manufacturers.


6) Zydus Lifesciences

Zydus Lifesciences, formerly known as Cadila Healthcare, is headquartered in Ahmedabad and operates manufacturing plants across several Indian states. It has been expanding aggressively into biologics, biosimilars, vaccines, and complex generics, including monoclonal antibodies and peptide-based drugs. It made headlines for being among the first companies approved to sell semaglutide, a popular diabetes and weight-loss medicine, in India, and licensed related pen-delivery technology to other Indian pharma companies.


7) Lupin

Lupin, headquartered in Mumbai, is one of India's major generic drug makers, with a strong presence in respiratory, cardiovascular, diabetes, and anti-infective medicines. It has a notable manufacturing and research footprint both in India and overseas, including facilities supporting its large US generics business, and it has also been investing in biosimilars and complex generics that require more advanced manufacturing know-how than simple tablets.


8) Mankind Pharma

Mankind Pharma, headquartered in New Delhi, has grown into one of India's largest pharmaceutical companies by focusing heavily on the domestic Indian market rather than exports. It is known for popular consumer healthcare brands such as Manforce and the pregnancy test brand Prega News, alongside a large prescription business covering anti-infectives, cardiology, and gastroenterology. This mix of branded generics and well-marketed consumer products has built strong recognition among doctors and everyday consumers alike.


9) Torrent Pharmaceuticals

Torrent Pharmaceuticals, based in Ahmedabad, is particularly well known for its strength in cardiovascular and central nervous system medicines, a leading position it holds in the Indian market. It also has a meaningful international presence, including operations in Brazil and Germany, alongside its US generics business, and has grown partly through strategic acquisitions of other companies' brands while keeping a focused, therapy-driven product strategy.


10) Biocon

Biocon, founded in 1978 by Kiran Mazumdar-Shaw in Bangalore, started as an enzyme manufacturing company before evolving into one of India's most important biotechnology and biosimilars companies. It played a pioneering role developing more affordable versions of complex biologic drugs used to treat diabetes, cancer, and autoimmune diseases. Its dedicated arm, Biocon Biologics, partners with global companies to develop and manufacture biosimilar products worldwide, setting it apart from more generics-focused peers.


Ahmedabad, Mumbai, Hyderabad, India's pharma giants keep clustering in the same handful of cities.

Here's what makes each one a magnet for manufacturing and R&D.

→ Read: Top 7 Biopharma Hubs in India Leading Innovation

Mind map graphic detailing the specialized innovators from the top 20 pharmaceutical companies in india.

11) Alkem Laboratories

Alkem Laboratories, headquartered in Mumbai, is one of India's leading domestic pharmaceutical companies, particularly well known for its anti-infective medicines, including its popular Clavam brand. It has built a strong distribution network reaching deep into smaller Indian towns and cities, plus a growing international business including a US presence. Its focus on acute therapies, meaning medicines for short-term illnesses, has traditionally been a core strength alongside a steadily expanding chronic disease portfolio.


12) Glenmark Pharmaceuticals

Glenmark Pharmaceuticals, based in Mumbai, has built a strong reputation in dermatology and respiratory medicine, two specialty areas where it holds a significant share of the Indian market. It also runs an active research and innovation arm working on novel drug molecules, somewhat less common among Indian generic-focused pharma companies, and it exports to the United States and parts of Europe alongside its Indian manufacturing base.


13) Ipca Laboratories

Ipca Laboratories, headquartered in Mumbai, is especially recognized for its anti-malarial medicines, an area where it has become one of the largest global suppliers, alongside a strong pain management and cardiovascular portfolio. It operates a vertically integrated manufacturing model, producing many of its own active pharmaceutical ingredients in-house rather than relying on outside suppliers, which gives it more control over supply chain and quality. Ipca exports to over a hundred countries.


14) Intas Pharmaceuticals

Intas Pharmaceuticals, headquartered in Ahmedabad, has grown into one of India's most research-driven pharma companies, with a strong focus on biosimilars, oncology, and central nervous system medicines. It owns Accord Healthcare, a UK-based subsidiary giving it a significant footprint in European generics markets, and it has built a reputation for bringing complex, hard-to-manufacture biosimilar products to market. Despite being privately held, Intas is considered one of the more influential names in Indian pharma today.


15) Emcure Pharmaceuticals

Emcure Pharmaceuticals, headquartered in Pune, has built a diverse portfolio spanning gynecology, HIV medicines, cardiovascular drugs, and vaccines. It has a significant domestic sales presence in India along with export operations reaching several international markets, and it has also been involved in vaccine manufacturing partnerships. It is generally seen as one of the stronger mid-to-large sized private pharmaceutical companies operating out of western India.


16) Wockhardt

Wockhardt, headquartered in Mumbai, is known for its work across biopharmaceuticals, generic medicines, and hospital services, since the company also operates a chain of Wockhardt Hospitals. It has invested significantly in developing new antibiotics, an area where global innovation has slowed even though drug-resistant infections remain a serious challenge, and it also manufactures biosimilars and insulin products, rounding out a fairly diverse therapeutic portfolio.


17) Natco Pharma

Natco Pharma, headquartered in Hyderabad, has built a distinctive reputation in the oncology generics space, often being among the first companies to launch more affordable versions of expensive cancer medicines once patents allow it. It has been involved in several notable legal cases related to compulsory licensing, a process allowing generic versions of patented drugs under certain conditions. Its identity remains closely tied to taking on complex, high-value oncology generics.


18) Ajanta Pharma

Ajanta Pharma, headquartered in Mumbai, has carved out a strong position in ophthalmology, cardiology, dermatology, and pain management medicines. It has a notable presence in African markets in addition to its Indian and other international operations, setting it apart from peers focused more on the US or Europe. Ajanta keeps a leaner, more focused product strategy, concentrating on therapy areas where it can build a strong specialist reputation.


19) Laurus Labs

Laurus Labs, headquartered in Hyderabad, is primarily known as a major manufacturer of active pharmaceutical ingredients, particularly for antiretroviral medicines used in HIV treatment, where it has become one of the largest suppliers globally. It has been expanding beyond APIs into finished dosage formulations and contract development and manufacturing services, showing how India's strength in chemical manufacturing supports treatment programs in many lower and middle-income countries.


20) Piramal Pharma

Piramal Pharma, headquartered in Mumbai, operates a different business model compared to most companies on this list, since a large part of its work involves contract development and manufacturing services for other pharma and biotech companies worldwide, alongside its own consumer healthcare and hospital generics businesses. This makes it one of India's most prominent CDMO players, with facilities spanning India, the United States, and the United Kingdom.


How to Choose the Right Pharmaceutical Partner in India

Not every company on this list serves the same purpose. Before shortlisting one, it helps to be clear on what you actually need:

  1. Business model fit — Are you looking for a branded generics giant, an API/CRAMS specialist, a CDMO partner, or a company with third-party/PCD franchise support? A company like Divi's or Laurus is built around API manufacturing, not consumer brands; Piramal and Intas lean CDMO; Mankind and Cipla lean domestic branded strength.
  2. Regulatory and quality certifications — For export-facing or institutional sourcing, check for US FDA, WHO-GMP, EU-GMP, or MHRA approvals on the specific facility you'd be working with, not just the company overall.
  3. Therapeutic area alignment — Match the company's specialization to your need. Respiratory and dermatology point toward Cipla or Glenmark; oncology generics point toward Natco or Dr. Reddy's; anti-malarials point toward Ipca.
  4. Scale vs. flexibility — Larger listed companies offer manufacturing capacity and global reach but can be slower to engage for smaller or custom orders. Mid-sized and specialty players often move faster and offer more tailored support.
  5. Export reach vs. domestic depth — If your priority is India-market distribution, a domestic-heavy player like Mankind or Alkem may serve you better than an export-heavy one like Aurobindo or Divi's.

There's no single "best" company on this list — the right fit depends on whether your priority is manufacturing scale, therapeutic specialization, export compliance, or partnership flexibility.


This list profiles the companies by therapy focus and business model, but where do they actually stand by market cap and revenue right now?

Here's the ranked breakdown for 2026.

→ Read: Top 10 Pharma Companies in India 2026 — Market Cap, Revenue & Ranking


Final Thoughts

This list is not a strict ranking from best to worst, since these companies differ widely in size, strategy, and specialty. Some, like Sun Pharma and Dr. Reddy's, are broad, globally diversified giants, while others, like Divi's Laboratories and Laurus Labs, have built their success by focusing tightly on active pharmaceutical ingredients and contract manufacturing rather than branded medicines. Companies like Natco Pharma and Ajanta Pharma show how a more specialized, focused strategy in a specific therapy area can still lead to a strong, respected position in the industry.

What ties all twenty companies together is India's broader role as a dependable, large-scale source of affordable, quality medicines for both its own population and much of the world. Whether you are a student learning about the pharmaceutical industry, an investor researching Indian stocks, or simply curious about where common generic medicines actually come from, this list offers a simple, accurate starting point into one of India's most important and fastest-growing industries, one that keeps expanding its role on the world stage every single year.


FAQs

1. What Are The Largest Pharmaceutical Companies In India?

Some of the largest pharmaceutical companies in India include Sun Pharmaceutical Industries, Dr. Reddy's Laboratories, Cipla, Divi's Laboratories, Aurobindo Pharma, and Lupin. These companies manufacture a wide range of generic medicines, specialty drugs, vaccines, biosimilars, and active pharmaceutical ingredients for both domestic and international markets. Many of them also have manufacturing facilities and business operations across multiple countries.


2. Why Is India Called The "Pharmacy Of The World"?

India is known as the "Pharmacy of the World" because it is one of the largest producers of generic medicines, vaccines, and active pharmaceutical ingredients (APIs). Indian pharmaceutical companies supply affordable, high-quality medicines to more than 200 countries, making healthcare more accessible worldwide. The country's strong manufacturing capabilities and regulatory expertise have made it a trusted global pharmaceutical supplier.


3. What Products Do Indian Pharmaceutical Companies Manufacture?

Indian pharmaceutical companies manufacture generic medicines, branded drugs, vaccines, biosimilars, active pharmaceutical ingredients (APIs), over-the-counter products, and specialty medicines for various therapeutic areas. Many companies also provide contract development and manufacturing services (CDMO) for global pharmaceutical and biotechnology firms. Their products are used to treat a wide range of conditions, including cancer, diabetes, cardiovascular diseases, infections, and respiratory disorders.

Author Profile

Simantini Singh Deo

Senior Content Writer

Comment your thoughts

Author Profile

Simantini Singh Deo

Senior Content Writer

Ad
Advertisement

You may also like

Article
Compliance In Pharma Manufacturing 2025: Key Regulations And Best Practices You Need to Know

Enoch Daniel